VICO
COM:VICOREPHARMA
Vicore Pharma Holding AB
- Stock
Last Close
7.78
22/11 08:09
Market Cap
2.17B
Beta: -
Volume Today
10.24K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -103K - | -105K 1.94% | -2K 98.10% | |||||||||
average payables | 626K - | 1.44M 129.55% | 2.25M 56.44% | 2.48M 10.41% | 2.58M 4.03% | 3.84M 48.80% | 8.12M 111.39% | 17.46M 115.03% | 23.74M 35.94% | 19.91M 16.13% | ||
average receivables | 103K - | 105K 1.94% | 2K 98.10% | 1.86M - | ||||||||
book value per share | 3.09 - | 4.15 34.21% | 5.82 40.24% | 5.39 7.36% | 6.65 23.37% | 12.47 87.60% | 7.47 40.10% | 6.53 12.54% | 5.50 15.82% | 4.00 27.23% | 4.72 17.81% | |
capex per share | -0.73 - | -0.40 45.21% | -0.96 139.20% | -1.19 23.95% | -0.09 92.66% | -0.00 96.09% | -0.06 1,519.21% | -0.04 - | ||||
capex to depreciation | -263.61 - | -942.83 257.66% | -2.25K 138.24% | -2.89K 28.68% | -285.71 90.12% | -0.11 99.96% | -0.85 672.01% | -0.83 - | ||||
capex to operating cash flow | 3.36 - | 1.54 54.26% | 1.86 20.97% | 2.63 41.28% | 0.06 97.69% | 0.00 97.21% | 0.03 1,380.38% | 0.01 - | ||||
capex to revenue | -6.73 - | -15.82 134.88% | -21.71 37.24% | -3.94 81.86% | ||||||||
cash per share | 1.08 - | 0.13 87.81% | 1.79 1,253.19% | 0.30 82.99% | 1.41 364.85% | 9.82 594.56% | 6.15 37.40% | 5.87 4.46% | 5.33 9.30% | 3.62 31.96% | 5.00 37.94% | |
days of inventory on hand | 28.43 - | |||||||||||
days payables outstanding | -349.79 - | -284.90 18.55% | -1.03K 262.99% | -652.87 36.87% | -383.63 41.24% | 90.32 - | ||||||
days sales outstanding | 80.68 - | 2.87 96.44% | ||||||||||
debt to assets | 0.03 - | |||||||||||
debt to equity | 0.03 - | |||||||||||
dividend yield | ||||||||||||
earnings yield | -0.02 - | 0.20 953.84% | -0.06 129.65% | -0.03 51.17% | -0.05 82.82% | -0.06 10.44% | -0.15 147.66% | -0.09 41.58% | -0.31 255.68% | -0.22 27.01% | -0.23 1.78% | |
enterprise value | 53.31M - | 67.13M 25.91% | 50.67M 24.52% | 221.82M 337.82% | 214.97M 3.09% | 140.29M 34.74% | 445.13M 217.30% | 1.46B 228.05% | 675.73M 53.72% | 1.04B 53.29% | 1.04B 0.02% | |
enterprise value over ebitda | -39.67 - | 4.85 112.24% | -11.17 330.04% | -33.39 199.02% | -16.81 49.65% | -5.61 66.63% | -4.81 14.23% | -10.06 109.03% | -2.32 76.91% | -3.62 55.87% | -4.06 12.25% | |
ev to operating cash flow | -23.76 - | -13.76 42.09% | -30.59 122.32% | -27.90 8.80% | -4.25 84.78% | -5.12 20.49% | -12.18 137.96% | -2.55 79.07% | -3.45 35.53% | -4.15 20.14% | ||
ev to sales | 60.32 - | 260.36 331.65% | 230.66 11.41% | 276.15 19.72% | ||||||||
free cash flow per share | -0.95 - | -0.66 30.30% | -1.48 122.85% | -1.64 11.28% | -1.53 6.89% | -2.02 32.23% | -2.27 11.92% | -3.81 67.94% | -4.19 10.22% | -2.58 38.38% | ||
free cash flow yield | -0.18 - | -0.12 32.67% | -0.09 25.55% | -0.12 27.51% | -0.10 17.88% | -0.14 43.48% | -0.07 47.77% | -0.27 280.03% | -0.23 14.28% | -0.18 22.21% | ||
graham net net | 0.24 - | -0.31 229.73% | 1.27 514.80% | -0.13 110.03% | 1.03 909.05% | 9.11 784.14% | 5.69 37.52% | 4.91 13.69% | 4.35 11.42% | 2.95 32.31% | 4.59 55.70% | |
graham number | 2.93 - | 9.93 238.52% | 6.52 34.39% | 7.58 16.36% | 10.64 40.30% | 16.31 53.27% | 19.07 16.93% | 19.95 4.63% | 22.95 15.03% | 18.97 17.35% | 18.49 2.54% | |
income quality | 0.53 - | 0.81 53.20% | 1.09 34.56% | 0.60 44.77% | 0.79 31.90% | 0.93 16.49% | 0.80 13.33% | 0.90 12.14% | 1.03 14.70% | 0.80 22.19% | ||
intangibles to total assets | 0.54 - | 0.63 15.39% | 0.48 23.32% | 0.69 43.72% | 0.60 12.51% | 0.23 61.93% | 0.20 13.00% | 0.17 12.80% | 0.15 14.14% | 0.20 34.81% | 0 100% | |
interest coverage | -13.68 - | -50.86 271.88% | -168.26 230.85% | -2.22K 1,217.21% | -206.34 90.69% | -125.80 39.03% | -3.48K 2,667.99% | -24.92K 615.77% | -26.80K 7.54% | -36.34K 35.59% | -896.34 97.53% | |
interest debt per share | 0.02 - | 0.12 632.88% | 0.00 98.45% | 0.00 88.84% | 0.00 1,606.26% | 0.02 321.54% | 0.00 95.92% | 0.00 82.37% | 0.00 42.74% | 0.00 29.83% | 0.00 3,246.76% | |
inventory turnover | 12.84 - | |||||||||||
invested capital | 0.03 - | |||||||||||
market cap | 67.34M - | 67.34M 0% | 75.84M 12.63% | 226.09M 198.11% | 238.99M 5.71% | 364.97M 52.71% | 632.72M 73.36% | 1.71B 170.08% | 969.92M 43.24% | 1.29B 33.27% | 1.37B 5.92% | |
net current asset value | 3.80M - | -3.58M 194.23% | 19.05M 632.60% | -1.25M 106.58% | 18.17M 1,548.64% | 210.66M 1,059.62% | 247.00M 17.25% | 275.85M 11.68% | 310.08M 12.41% | 220.87M 28.77% | 453.15M 105.17% | |
net debt to ebitda | 10.44 - | -0.02 100.15% | 5.55 36,637.66% | 0.64 88.43% | 1.88 192.53% | 8.99 378.32% | 2.03 77.43% | 1.71 15.55% | 1.01 40.96% | 0.90 11.25% | 1.31 45.86% | |
net income per share | -0.12 - | 1.06 953.84% | -0.32 130.69% | -0.47 46.15% | -0.76 59.55% | -0.95 25.23% | -2.16 128.25% | -2.71 25.18% | -4.25 57.17% | -3.99 6.13% | -3.22 19.37% | |
operating cash flow per share | -0.22 - | -0.26 19.80% | -0.52 97.73% | -0.45 12.27% | -1.44 218.35% | -2.02 40.00% | -2.21 9.38% | -3.81 72.14% | -4.15 9.13% | -2.58 37.76% | ||
payables turnover | -1.04 - | -1.28 22.78% | -0.35 72.45% | -0.56 58.40% | -0.95 70.18% | 4.04 - | ||||||
receivables turnover | 4.52 - | 127 2,707.08% | ||||||||||
research and ddevelopement to revenue | 40.28 - | |||||||||||
return on tangible assets | -0.07 - | 0.61 996.18% | -0.10 116.00% | -0.26 166.15% | -0.27 3.39% | -0.09 65.53% | -0.34 265.46% | -0.44 28.29% | -0.77 76.64% | -1.07 38.31% | -0.63 41.36% | |
revenue per share | 0.06 - | 0.06 1.84% | 0.05 9.69% | 0.02 59.53% | ||||||||
roe | -0.04 - | 0.25 736.20% | -0.06 121.88% | -0.09 57.75% | -0.11 29.32% | -0.08 33.25% | -0.29 281.06% | -0.41 43.12% | -0.77 86.71% | -1.00 28.99% | -0.68 31.56% | |
roic | -0.10 - | 0.04 135.08% | -0.06 254.33% | -0.09 58.62% | -0.11 24.65% | -0.30 173.71% | -0.29 2.83% | -0.42 44.23% | -0.77 82.74% | -1.00 30.69% | -0.70 29.93% | |
sales general and administrative to revenue | 4 - | 5.88 46.89% | 5.83 0.82% | 16.98 191.33% | ||||||||
shareholders equity per share | 3.09 - | 4.15 34.21% | 5.82 40.24% | 5.39 7.36% | 6.65 23.37% | 12.47 87.60% | 7.47 40.10% | 6.53 12.54% | 5.50 15.82% | 4.00 27.23% | 4.72 17.81% | |
stock based compensation to revenue | ||||||||||||
tangible asset value | 12.40M - | 16.59M 33.84% | 39.17M 136.09% | 19.36M 50.58% | 40.94M 111.48% | 216.24M 428.21% | 253.51M 17.24% | 283.76M 11.93% | 315.89M 11.32% | 220.98M 30.04% | 455.39M 106.07% | |
tangible book value per share | 3.09 - | 4.15 34.21% | 2.78 32.95% | 1.38 50.38% | 2.41 74.60% | 9.45 292.19% | 5.89 37.67% | 5.23 11.19% | 4.53 13.33% | 3.06 32.50% | 4.72 54.12% | |
working capital | 12.87M - | -1.60M 112.42% | 21.03M 1,415.13% | 724K 96.56% | 20.14M 2,682.32% | 212.91M 956.95% | 249.56M 17.21% | 279.76M 12.10% | 312.21M 11.60% | 223.37M 28.45% | 454.64M 103.53% |
All numbers in (except ratios and percentages)